Inovio Pharmaceuticals Inc (INO)
4.77
-0.18
(-3.64%)
USD |
NASDAQ |
Nov 14, 16:00
4.90
+0.13
(+2.73%)
After-Hours: 20:00
Inovio Pharmaceuticals Cash and Short Term Investments (Quarterly): 110.42M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 110.42M |
| March 31, 2024 | 105.61M |
| December 31, 2023 | 145.29M |
| September 30, 2023 | 167.47M |
| June 30, 2023 | 194.93M |
| March 31, 2023 | 223.75M |
| December 31, 2022 | 253.00M |
| September 30, 2022 | 281.88M |
| June 30, 2022 | 348.13M |
| March 31, 2022 | 360.39M |
| December 31, 2021 | 401.31M |
| September 30, 2021 | 394.94M |
| June 30, 2021 | 443.68M |
| March 31, 2021 | 518.60M |
| December 31, 2020 | 411.64M |
| September 30, 2020 | 337.24M |
| June 30, 2020 | 371.66M |
| March 31, 2020 | 270.00M |
| December 31, 2019 | 89.53M |
| September 30, 2019 | 93.80M |
| June 30, 2019 | 105.97M |
| March 31, 2019 | 128.00M |
| December 31, 2018 | 81.23M |
| September 30, 2018 | 85.49M |
| June 30, 2018 | 95.60M |
| Date | Value |
|---|---|
| March 31, 2018 | 112.77M |
| December 31, 2017 | 127.43M |
| September 30, 2017 | 141.89M |
| June 30, 2017 | 92.00M |
| March 31, 2017 | 89.66M |
| December 31, 2016 | 104.77M |
| September 30, 2016 | 119.69M |
| June 30, 2016 | 134.53M |
| March 31, 2016 | 146.79M |
| December 31, 2015 | 162.99M |
| September 30, 2015 | 170.78M |
| June 30, 2015 | 154.59M |
| March 31, 2015 | 81.01M |
| December 31, 2014 | 93.62M |
| September 30, 2014 | 100.93M |
| June 30, 2014 | 108.86M |
| March 31, 2014 | 116.78M |
| December 31, 2013 | 52.63M |
| September 30, 2013 | 46.17M |
| June 30, 2013 | 23.46M |
| March 31, 2013 | 28.07M |
| December 31, 2012 | 13.68M |
| September 30, 2012 | 15.14M |
| June 30, 2012 | 19.44M |
| March 31, 2012 | 24.86M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
89.53M
Minimum
Dec 2019
518.60M
Maximum
Mar 2021
285.76M
Average
281.88M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Baxter International Inc | 1.42B |
| Novavax Inc | 1.050B |
| AIM ImmunoTech Inc | 10.06M |
| Protalix BioTherapeutics Inc | 45.03M |
| Armata Pharmaceuticals Inc | 26.40M |